Agilent Technologies Inc. (A) Stock Price

AStock

$153.84+23.11%52W

Market Cap$43.38B

P/E31.87x

PEG Ratio1.41

Div yield0.75%

Beta1.24

A Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)11.74%

Price vs S&P 500 (4W)8.50%

PEG Ratio1.41

VGM Score56.16

P/E Ratio (Annual)31.87x

Indicated Dividend Yield (Annual)0.75%

P/CF (Annual)26.63x

Book Value / Share (Quarterly)$25.24

P/TBV (Annual)6.59x

Indicated Dividend (Annual)$1.02

Revenue Growth (3Y)0.48%

Cash Flow / Share (Quarterly)$3.85

Payout Ratio (TTM)20.16%

Price vs S&P 500 (YTD)0.24%

Gross Margin (TTM)52.93%

Net Profit Margin (TTM)19.55%

EPS (TTM)$4.97

10-Day Avg Trading Volume2.71M

EPS Excl Extra (TTM)$4.97

Revenue Growth (5Y)5.41%

EPS (Annual)$4.57

Dividend / Share (Annual)$0.99

ROI (Annual)12.91%

Gross Margin (Annual)52.73%

Net Profit Margin (5Y Avg)18.83%

Cash / Share (Quarterly)$6.40

P/E Basic Excl Extra (TTM)29.37x

Revenue Growth QoQ (YoY)10.01%

EPS Growth (5Y)14.68%

P/E Normalized (Annual)31.87x

ROA (Last FY)10.24%

Revenue Growth TTM (YoY)9.11%

EBITD / Share (TTM)$6.45

ROE (5Y Avg)21.70%

Operating Margin (TTM)21.50%

Cash Flow / Share (Annual)$4.07

P/B Ratio5.83x

P/B Ratio (Quarterly)4.58x

Net Income / Employee (Annual)$72,400

EV / Revenue (TTM)5.96x

Net Interest Coverage (TTM)17.31x

ROA (TTM)11.13%

EPS Growth QoQ (YoY)58.79%

EV / EBITDA (TTM)23.51x

EPS Incl Extra (Annual)$4.57

Current Ratio (Annual)1.96x

Quick Ratio (Quarterly)1.62x

3-Month Avg Trading Volume2.29M

52-Week Price Return23.11%

EV / Free Cash Flow (Annual)37.39x

P/E Incl Extra (TTM)29.37x

Revenue / Employee (TTM)$401,800

Tangible BV / Share (Quarterly)$23.79

P/S Ratio (Annual)5.98x

Asset Turnover (Annual)0.55x

52-Week High$163.75

Operating Margin (5Y Avg)21.94%

EPS Excl Extra (Annual)$4.57

CapEx CAGR (5Y)27.88%

Tangible BV CAGR (5Y)9.27%

26-Week Price Return23.67%

Quick Ratio (Annual)1.52x

13-Week Price Return13.64%

Total Debt / Equity (Annual)0.50x

Current Ratio (Quarterly)2.10x

Enterprise Value$43.07B

Revenue / Share Growth (5Y)7.34%

Asset Turnover (TTM)0.57x

Book Value / Share Growth (5Y)8.38%

Revenue / Employee (Annual)$386,000

Inventory Turnover (Annual)3.29x

Pretax Margin (Annual)20.65%

Cash / Share (Annual)$6.32

3-Month Return Std Dev43.39%

Gross Margin (5Y Avg)53.27%

Net Income / Employee (TTM)$78,600

EBITDA CAGR (5Y)9.07%

EBITDA Interim CAGR (5Y)5.01%

ROE (Last FY)19.33%

Net Interest Coverage (Annual)28.24x

EPS Basic Excl Extra (Annual)$4.57

P/FCF (TTM)38.20x

Receivables Turnover (TTM)5.05x

EV / Free Cash Flow (TTM)39.62x

Total Debt / Equity (Quarterly)0.47x

EPS Incl Extra (TTM)$4.97

Receivables Turnover (Annual)4.94x

ROI (TTM)13.93%

Dividend Growth Rate (5Y)6.57%

P/S Ratio (TTM)5.74x

Pretax Margin (5Y Avg)21.42%

Revenue / Share (Annual)$24.38

Tangible BV / Share (Annual)$22.24

Forward P/E21.48x

Free OCF CAGR (5Y)7.51%

Price vs S&P 500 (52W)4.55%

P/E Ratio (TTM)29.37x

EPS Growth TTM (YoY)22.41%

Year-to-Date Return13.06%

5-Day Price Return0.27%

EPS Normalized (Annual)$4.57

ROA (5Y Avg)11.17%

Net Profit Margin (Annual)18.75%

Month-to-Date Return11.18%

Cash Flow / Share (TTM)$5.11

EBITD / Share (Annual)$6.25

EPS Growth (3Y)3.03%

Operating Margin (Annual)21.49%

LT Debt / Equity (Annual)0.45x

P/CF (TTM)28.60x

ROI (5Y Avg)14.34%

P/E Excl Extra (TTM)29.37x

LT Debt / Equity (Quarterly)0.43x

EPS Basic Excl Extra (TTM)$4.97

P/TBV (Quarterly)4.86x

Payout Ratio (Annual)21.64%

P/B Ratio (Annual)6.16x

Dividend / Share (TTM)$1.01

Inventory Turnover (TTM)3.27x

Pretax Margin (TTM)21.85%

Book Value / Share (Annual)$23.82

Price vs S&P 500 (13W)11.68%

Net Margin Growth (5Y)6.84%

Dividend Yield (TTM)0.69%

Beta1.24x

P/FCF (Annual)36.04x

Revenue / Share (TTM)$25.55

ROE (TTM)20.84%

52-Week Low$108.35

vGradeD

gGradeC

mGradeB

vgmGradeC

A Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 26, 2026	$1.49	$1.62	+9.01%(+$0.13)
Q1 2026	May 27, 2026	$1.41	$1.49	+5.80%(+$0.08)
Q4 2025	Feb 25, 2026	$1.37	$1.36	-0.60%(-$0.01)
Q3 2025	Nov 24, 2025	$1.58	$1.59	+0.37%(+$0.01)
Q2 2025	Aug 27, 2025	$1.37	$1.37	+0.17%(+$0.00)

A Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

4.04

4.07

4.03

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
AAgilent Technologies Inc.	D	C	B	$153.84
WATWaters Corp	D	C	B	$414.69
ILMNIllumina Inc	D	D	A	$215.59
MTDMettler-Toledo International	D	C	B	$1398.58
RVTYRevvity, Inc.	C	D	A	$128.80
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$387.70
AVTRAvantor, Inc.	B	F	A	$14.58
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
BRKRBruker Corporation	D	D	B	$57.08
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$61.54
ALMRAlamar Biosciences, Inc. Common Stock	—	—	B	$30.71
CTKBCytek Biosciences, Inc. Common Stock	C	C	B	$4.68
MASS908 Devices Inc. Common Stock	C	C	B	$10.73
PACBPacific Biosciences of California, Inc.	D	C	C	$1.40
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$25.76
EYPTEyePoint, Inc. Common Stock	D	F	F	$4.48
LABStandard BioTools Inc. Common Stock	A	F	D	$0.64
QTRXQuanterix Corporation Common Stock	A	C	D	$2.64
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.89
SEERSeer, Inc. Class A Common Stock	C	D	C	$1.98
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.57
PRPOPrecipio, Inc. Common Stock	C	A	B	$28.85
HBIOHarvard Bioscience Inc	B	F	A	$7.93
ASTCAstrotech Corporation (DE) Common Stock	C	C	C	$7.15
BNGOBionano Genomics, Inc. Common Stock	A	C	D	$1.17
HLTHTema Healthcare AI ETF	—	F	F	$28.54
PRENWPrenetics Global Limited Warrant	—	—	F	$0.01

About Agilent Technologies Inc.

Agilent Technologies, spun out of Hewlett-Packard in 1999, is a leading measurement and diagnostics company serving life sciences, diagnostics, and applied end markets through consumables, services, and instruments. Over 50% of revenue comes from biopharmaceutical, chemical, and advanced materials customers—sticky, mission-critical applications—while also serving clinical, environmental, forensics, food, and academic markets. The company maintains geographic diversification with significant operations in the US and China.